Hudson Bay Capital Management LP Solid Biosciences Inc. Transaction History

Hudson Bay Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$21.32 - $46.34 $533,000 - $1.16 Million	-25,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$36.35 - $51.7 $363,500 - $517,000	-10,000 Reduced 28.57%	25,000 $1.18 Million
Q2 2018 Aug 13, 2018	BUY	$7.33 - $43.15 $256,550 - $1.51 Million	35,000 New	35,000 $1.25 Million

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $28.2M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hudson Bay Capital Management LP with notifications on news.